An open-label clinical trial analyzing the efficacy of a novel telomere-protecting antiaging face cream

HIGHLIGHTS

  • who: Christina Alt and colleagues from the Department of Dermatology, Venereology and Allergology, University Hospital Essen, University of Duisburg-Essen, Hufelandstr55, Essen, Germany have published the research work: An Open-Label Clinical Trial Analyzing the Efficacy of a Novel Telomere-Protecting Antiaging Face Cream, in the Journal: Cosmetics 2022, 9, 95. of /2022/
  • what: This study investigated the effect of a cycloartane-type triterpene glycoside (astragaloside IV). It was observed that 13 of the 15 participants included in the study presented an improvement in their telomere length profile when treated with the cream containing astragaloside . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?